Previous Close | 41.43 |
1-Year Change | -15.64% |
6-Months Change | 7.39% |
3-Months Change | -8.76% |
Moving Avg (50d) | 39.139 |
Moving Avg (200d) | 40.818 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.83B |
Beta (3-Years) | 1.76 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -121.37% |
EPS (ttm) | -7.22 |
PE Ratio (ttm) | -5.74 |
Dividend Yield | % |
Asset Description: | Biohaven Ltd. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-27 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
42.259 | 43.502 | 44.33 | 45.573 | 47.645 | 49.716 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |